6,678 trials
Interstitial Cystitis/Painful Bladder Syndrome · Myofascial Pelvic Pain
Primary: Total Score on Genitourinary Pain Index (GUPI) Scale — 24.4; 22.2; 2.35; 29.25 score on a scale
Multiple Sclerosis, Relapsing-Remitting
Primary: Change in Peripheral B-cell Tolerance Checkpoints in People With MS Before and After Ocrelizumab Therapy.
Cataract
Primary: Binocular Distance Corrected Intermediate Visual Acuity at 66 cm Under Mesopic Conditions. — 0.27; 0.32 logMAR
Overactive Bladder · Urinary Urge Incontinence · Overactive Bladder Syndrome
Primary: Change in Overactive Bladder Questionnaire Long Form Score (Symptoms Severity Sub-scale)(OAB-Q LF) — -31.2; -39.5 units on a scale
Knee Osteoarthritis · Arthroplasty Complications · Postoperative Pain
Primary: Pain Status as Measured by Numeric Pain Scale — 2; 4.00 score on a scale
Ulcerative Colitis · Crohn Disease
Primary: Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESIs) — 54; 29; 6; 2 Participants
Dysphagia
Primary: Change in the Occurrence of Dysphagia -Bazaz Scale — 2.17; 3.27 score on a scale
COPD Exacerbation
Primary: The Primary Objective of the Study is to Determine the Percentage of Patients With "Therapeutic Success" at the End of the Cycle of Antibiotic Therapy (10 Days), in the…
Dementia · Dementia With Lewy Bodies · Dementia in Parkinsons Disease
Primary: Change of Mini Mental State Examination (MMSE) Test Result — -0.27; -0.90 difference in MMSE units on a scale
Pancreatic Neuroendocrine Tumors
Primary: Number of Participants With Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 60; 30; 58; 19 Participants
Neuromuscular Blockade
Primary: Urine Residual in PACU — 219; 222 ml
Overweight and Obesity
Primary: Blood Oxygen Level-dependent (BOLD) Response to High-calorie Foods Cues Minus Neutral Objects in Left Anterior Cingulate Cortex — -0.05; -0.16 percent BOLD signal change
Diabetes Mellitus, Type 2
Primary: Number of Adverse Events (AEs) — 45 Events
Postdural Puncture Headache
Primary: Number of Participants With Postdural Puncture Headache — 3; 4; 8; 10 Participants
Cesarean Section Complications
Primary: Postoperative Oxycodone Consumption 0- 48 Hours After Cesarean Delivery — 12.5; 25 mg